510(k) Report

510(k) · Cleared

Cleared

Monoplace Hyperbaric Oxygen Treatment System, Model BLKS-307

K060739510(k) SpecialCleared Jul 21, 2006123-day reviewClass II21 CFR 868.5470

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Khrunichev State Research & Production Space Centr · CBF Chamber, Hyperbaric

Cleared on Jul 21, 2006 as substantially equivalent to K011312 (Khrunichev State Research & Production Space Centr, 2001) after a 123-day review. Its family tree reaches back 1 generation to 2001. 3 later devices descend from it.

Decided
Jul 21, 2006
Review
123 days
Class
Class II
Product code
CBF
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K011312 (2001). 3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2019: 1 descendant cleared2023: 1 descendant clearedK011312 · BLKS-303 MK Monoplace Hyperbaric System · Khrunichev State Research & Production Space Centr · 2001200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K011312 · BLKS-303 MK Monoplace Hyperbaric System · Khrunichev State Research & Production Space Centr · 20010
  1. Root · 1 generation backK011312 BLKS-303 MK Monoplace Hyperbaric SystemKhrunichev State Research & Production Space Centr · 2001
  2. This deviceK060739 Monoplace Hyperbaric Oxygen Treatment System, Model BLKS-307Khrunichev State Research & Production Space Centr · 2006
  3. Descendant · cites it directly · 2 of its ownK072757 Dive and Shallow and Grand DiveSummit TO Sea · 2008
  4. Descendant · 2 generations on · 1 of its ownK171899 Revitalair 430FOxavita Srl · 2019
  5. Descendant · 3 generations on · 0 of its ownK220290 Revitalair 430+Us Hyperbaric Network · 2023

Most influential descendants

Showing 3 of 3 · See all
  • K072757Dive and Shallow and Grand DiveSummit TO Sea · 2008 · cites it directly2descendants
  • K171899Revitalair 430FOxavita Srl · 2019 · 2 generations on1descendant
  • K220290Revitalair 430+Us Hyperbaric Network · 2023 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K011312BLKS-303 MK Monoplace Hyperbaric SystemKhrunichev State Research & Production Space Centr2001—
0 (this device)K060739Monoplace Hyperbaric Oxygen Treatment System, Model BLKS-307Khrunichev State Research & Production Space Centr2006—
+1K072757Dive and Shallow and Grand DiveSummit TO Sea2008—
+2K171899Revitalair 430FOxavita Srl2019—
+3K220290Revitalair 430+Us Hyperbaric Network2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201910
202310
FIG. 1 — Lineage of K060739, 2001–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CBF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CBF device

  1. #1 K240569 FESL FINK Chamber; FEDL FINK Chamber; FETL…score 8.7 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011312BLKS-303 MK Monoplace Hyperbaric System
Summary page 2
…Khrunichev Parameters Units BLKS-303MK Khrunichev K011312. BLKS-307 Internal Diameter In (mm) 28.7 (730) 42,1 (1080) Length…
Khrunichev State Research & Production Space Centr2001—

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K072757Dive and Shallow and Grand DiveSummit TO Sea20082

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K072757 (Summit TO Sea, 2008) has gone furthest, with 2 descendants of its own.

How does its category compare?

All CBF devices

CBF Chamber, Hyperbaric: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CBF

1in 2024

2008: 32009: 12010: 32011: 12014: 12016: 12017: 12019: 12023: 12024: 1
2007high 3 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CBF

87in 2010

2008: 134 days median2010: 87 days median
2007high 134 (2008) · low 87 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CBF

2in 2008

2008: 2
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CBF

25in 2025

2007: 22009: 12010: 112011: 52012: 92013: 12014: 52015: 32016: 52017: 92018: 52019: 32020: 42021: 62022: 92023: 132024: 132025: 25
2007high 25 (2025) · low 0 (2008)2025

MAUDE reports naming product code CBF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
2008313420
20091—01
2010387011
20111—05
20120—09
20130—01
20141—05
20150—03
20161—05
20171—09
20180—05
20191—03
20200—04
20210—06
20220—09
20231—013
20241—013
20250—025
20260—0—

What is it indicated for?

The conditions listed as appropriate for the use of the Hyperbaric Oxygen Therapy in the current edition of Undersea and Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report (1999) are as follows: * Air or gas embolism * Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning * Clostridial myositis and myonecrosis * Crush injury, compartment syndrome, and other acute traumatic ischemias *…

Read the full statement (109 words)

The conditions listed as appropriate for the use of the Hyperbaric Oxygen Therapy in the current edition of Undersea and Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report (1999) are as follows:

* Air or gas embolism

* Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning

* Clostridial myositis and myonecrosis

* Crush injury, compartment syndrome, and other acute traumatic ischemias

* Decompression sickness

* Enhanced healing of selected problem wounds

* Exceptional blood loss anemia

* Necrotizing soft tissue infections

* Osteomyelitis (refractory)

* Delayed radiation injury (soft tissue and bony necrosis)

* Skin grafts and flaps (compromised)

* Thermal burns

* Intracranial abscess

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060739: Monoplace Hyperbaric Oxygen Treatment System, Model BLKS-307.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K060739

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026